Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
What we know Consuming flavonoid-rich food and beverages has been associated with a reduced risk of CHD
[1] There is no regulatory or clinical rationale for including tirzepatide in routine drug screening protocols
Individual results may vary, but many patients experience significant weight loss of 5-10% of their body weight or more within a few months of starting treatment
Substantial metabolic changes could theoretically influence the hypothalamic-pituitary-gonadal axis Nutritional considerations : Markedly reduced food intake might lead to inadequate consumption of nutrients that support hormone production and energy levels, particularly with severe appetite suppression Gastrointestinal side effects : Persistent nausea, bloating, or digestive discomfort (common with semaglutide) can understandably diminish sexual desire and comfort during intimacy Dehydration and low energy : Gastrointestinal side effects may lead to fluid loss and reduced energy levels that could affect overall wellbeing Psychological and emotional factors are equally important: Body image changes : Whilst weight loss is often desired, rapid physical changes can affect self-perception and confidence, potentially impacting sexual relationships Mood alterations : Changes in eating patterns, blood sugar fluctuations, and adjustment to medication may influence mood and emotional wellbeing Relationship dynamics : Weight loss and lifestyle changes can alter relationship patterns and communication around intimacy Underlying health conditions must also be considered
US$ 20.81
US$ 21.59
US$ 27.50
US$ 21.11
US$ 26.02
US$ 27.72
US$ 24.86
US$ 28.83
US$ 28.61
US$ 25.38
